Income Statement Marksans Pharma Limited

Equities

MARKSANS

INE750C01026

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 12:39:38 2024-09-10 am EDT			5-day change	1st Jan Change
262.38 ^INR	+1.55%		+8.45%	+63.22%

Aug. 21	Marksans Pharma Arm Gets UK Regulator's Marketing Nod for Fluoxetine Capsules	MT
Aug. 20	Marksans Pharma Gets US FDA's EIR for Goa, India Unit	MT

5105fa61135eb24d7130875c264ba6c.3irfE8tL6tC2Z4DhkwVd3AzoEcEJaU9R14Bngr1hIME.mWm3IbsziZXnDrKs51Yxhm25fJFYKD5pofAQt4wXapC6e5d7-Srcn_kLyQ

Published financial data: MARKSANS PHARMA LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	11.34B	13.76B	14.91B	18.52B	21.77B
Other Revenues, Total	-	38.73M	-	-	-
Total Revenues	11.34B	13.8B	14.91B	18.52B	21.77B
Cost of Goods Sold, Total	5.53B	6.06B	7.3B	9.4B	10.69B
Gross Profit	5.81B	7.75B	7.61B	9.12B	11.08B
Selling General & Admin Expenses, Total	1.79B	2.1B	2.25B	2.52B	3.06B
Depreciation & Amortization - (IS)	222M	314M	448M	519M	743M
Other Operating Expenses	2.1B	2.2B	2.77B	3.2B	3.44B
Other Operating Expenses, Total	4.11B	4.61B	5.47B	6.24B	7.24B
Operating Income	1.7B	3.13B	2.14B	2.88B	3.84B
Interest Expense, Total	-58.14M	-38.18M	-57.4M	-60.96M	-112M
Interest And Investment Income	1M	11.59M	59.73M	120M	338M
Net Interest Expenses	-57.14M	-26.59M	2.33M	59.41M	226M
Currency Exchange Gains (Loss)	-	-9.67M	206M	398M	82.4M
Other Non Operating Income (Expenses)	-27.82M	-25.44M	125M	44.67M	82.1M
EBT, Excl. Unusual Items	1.62B	3.07B	2.47B	3.38B	4.23B
Impairment of Goodwill	-44.98M	-47.9M	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	520K
Gain (Loss) On Sale Of Assets	249K	296K	-	-2.64M	940K
Insurance Settlements	525K	-	1.16M	-	390K
EBT, Incl. Unusual Items	1.57B	3.02B	2.48B	3.38B	4.24B
Income Tax Expense	364M	636M	607M	723M	1.09B
Earnings From Continuing Operations	1.21B	2.39B	1.87B	2.65B	3.15B
Net Income to Company	1.21B	2.39B	1.87B	2.65B	3.15B
Minority Interest	-	-	-	-	-11.95M
Net Income - (IS)	1.21B	2.39B	1.87B	2.65B	3.14B
Net Income to Common Incl Extra Items	1.21B	2.39B	1.87B	2.65B	3.14B
Net Income to Common Excl. Extra Items	1.21B	2.39B	1.87B	2.65B	3.14B
Per Share Items
Net EPS - Basic	2.95	5.83	4.56	6.39	6.92
Basic EPS - Continuing Operations	2.95	5.83	4.56	6.39	6.92
Basic Weighted Average Shares Outstanding	409M	409M	409M	415M	453M
Net EPS - Diluted	2.95	5.83	4.56	6.39	6.92
Diluted EPS - Continuing Operations	2.95	5.83	4.56	6.39	6.92
Diluted Weighted Average Shares Outstanding	409M	409M	409M	415M	453M
Normalized Basic EPS	2.47	4.69	3.78	5.08	5.81
Normalized Diluted EPS	2.47	4.69	3.78	5.08	5.81
Dividend Per Share	0.1	0.25	0.25	0.5	0.6
Payout Ratio	24.43	1.72	5.66	3.83	7.22
Supplemental Items
EBITDA	1.91B	3.39B	2.4B	3.2B	4.34B
EBITA	1.73B	3.19B	2.18B	2.98B	3.96B
EBIT	1.7B	3.13B	2.14B	2.88B	3.84B
EBITDAR	2.02B	3.51B	2.45B	3.33B	4.46B
Total Revenues (As Reported)	11.35B	13.83B	15.33B	19.11B	22.28B
Effective Tax Rate - (Ratio)	23.17	21.06	24.52	21.42	25.65
Total Current Taxes	324M	667M	571M	712M	1.14B
Total Deferred Taxes	44.66M	-30.68M	35.87M	10.98M	-51.05M
Normalized Net Income	1.01B	1.92B	1.55B	2.11B	2.63B
Interest on Long-Term Debt	8.44M	22.98M	42.23M	34.12M	60.31M
Non-Cash Pension Expense	160K	711K	780K	1.01M	1.95M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	83.15M	127M	192M	159M	231M
Net Rental Expense, Total	101M	123M	47.44M	129M	122M
Imputed Operating Lease Interest Expense	65.07M	102M	29.07M	53.9M	59.79M
Imputed Operating Lease Depreciation	36.26M	21.15M	18.37M	75.25M	62.64M
Maintenance & Repair Expenses, Total	82.95M	105M	127M	187M	312M

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	937M	2.12B	3.49B	3.82B	4.03B
Short Term Investments	-	-	-	3.33B	2.71B
Trading Asset Securities, Total	-	-	4.35M	5.4M	270M
Total Cash And Short Term Investments	937M	2.12B	3.5B	7.16B	7.01B
Accounts Receivable, Total	2.43B	2.71B	3.95B	4.17B	4.53B
Other Receivables	-	-	43.7M	48.5M	107M
Total Receivables	2.43B	2.71B	3.99B	4.22B	4.64B
Inventory	2.42B	4.04B	4.24B	4.85B	6.18B
Prepaid Expenses	-	-	-	198M	251M
Other Current Assets, Total	113M	143M	279M	333M	543M
Total Current Assets	5.9B	9.02B	12.01B	16.75B	18.62B
Gross Property Plant And Equipment	3.63B	4.1B	5.47B	6.23B	9.81B
Accumulated Depreciation	-1.33B	-1.56B	-2.04B	-2.36B	-3B
Net Property Plant And Equipment	2.3B	2.54B	3.42B	3.87B	6.81B
Long-term Investments	-	-	-	-	1.68M
Goodwill	244M	196M	300M	385M	395M
Other Intangibles, Total	483M	474M	586M	708M	648M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	6.34M	7.99M	38.57M	-	-
Other Long-Term Assets, Total	33.02M	41.58M	41.62M	189M	329M
Total Assets	8.97B	12.28B	16.4B	21.9B	26.81B
Liabilities
Accounts Payable, Total	1.05B	1.69B	2B	2.31B	2.68B
Accrued Expenses, Total	77.89M	98.2M	131M	221M	443M
Short-term Borrowings	188M	187M	363M	416M	291M
Current Portion of Long-Term Debt	458K	-	50M	-	-
Current Portion of Leases	-	60.37M	281M	157M	250M
Current Income Taxes Payable	119M	300M	173M	253M	199M
Other Current Liabilities	767M	651M	564M	57.59M	33.66M
Total Current Liabilities	2.2B	2.98B	3.56B	3.41B	3.9B
Long-Term Debt	50M	50M	-	-	-
Long-Term Leases	108M	93.26M	414M	657M	1.9B
Pension & Other Post Retirement Benefits	11.51M	14.17M	15.73M	23.22M	38.96M
Deferred Tax Liability Non Current	108M	80.63M	176M	154M	106M
Other Non Current Liabilities	3.23M	6.94M	2.83M	9.3M	6.63M
Total Liabilities	2.48B	3.23B	4.17B	4.25B	5.95B
Preferred Stock Redeemable	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	409M	409M	409M	453M	453M
Additional Paid In Capital	1.75B	1.75B	1.73B	5.04B	5.04B
Retained Earnings	3.99B	6.49B	8.23B	10.91B	13.83B
Comprehensive Income and Other	211M	218M	1.65B	1.04B	1.33B
Total Common Equity	6.36B	8.86B	12.02B	17.45B	20.65B
Minority Interest	131M	189M	207M	199M	209M
Total Equity	6.49B	9.05B	12.23B	17.65B	20.86B
Total Liabilities And Equity	8.97B	12.28B	16.4B	21.9B	26.81B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	409M	409M	409M	453M	453M
ECS Total Common Shares Outstanding	409M	409M	409M	453M	453M
Book Value / Share	15.54	21.66	29.37	38.51	45.57
Tangible Book Value	5.63B	8.19B	11.14B	16.36B	19.61B
Tangible Book Value Per Share	13.76	20.02	27.21	36.1	43.27
Total Debt	346M	391M	1.11B	1.23B	2.44B
Net Debt	-591M	-1.73B	-2.39B	-5.93B	-4.57B
Debt Equivalent of Unfunded Proj. Benefit Obligation	20.25M	19.62M	21.64M	31.65M	55.75M
Debt Equivalent Oper. Leases	811M	985M	380M	1.03B	979M
Minority Interest, Total (Incl. Fin. Div)	131M	189M	207M	199M	209M
Account Code - Inventory Valuation	8	6	6	6	6
Inventories - Raw Materials, Total	917M	1.18B	1.51B	2.03B	2.62B
Inventories - Work In Process, Total	157M	148M	107M	205M	248M
Inventories - Finished Goods, Total	1.34B	2.72B	2.63B	2.61B	3.31B
Land - (BS)	13.81M	4.14M	4.67M	5.1M	5.18M
Buildings, Total	1.26B	1.32B	1.51B	1.63B	2.29B
Machinery, Total	2.24B	2.52B	3.04B	3.36B	4.44B
Full Time Employees	1.15K	1.14K	890	852	1.14K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	37.12M	52.68M

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	1.21B	2.39B	1.87B	2.65B	3.14B
Depreciation & Amortization - CF	188M	244M	407M	414M	620M
Amortization of Goodwill and Intangible Assets - (CF)	28.18M	63.79M	34.96M	105M	121M
Depreciation & Amortization, Total	216M	308M	442M	519M	741M
Amortization of Deferred Charges, Total - (CF)	5.92M	5.92M	5.92M	-	2.15M
(Gain) Loss From Sale Of Asset	-249K	-367K	-	2.64M	-940K
(Gain) Loss on Sale of Investments - (CF)	-	-17.75M	-56.23M	108M	-43.63M
Asset Writedown & Restructuring Costs	44.98M	47.9M	-	-	-
Provision and Write-off of Bad Debts	-	143M	26.32M	144M	51.57M
Other Operating Activities, Total	268M	416M	-186M	62.76M	-321M
Change In Accounts Receivable	-668M	-423M	-1.04B	-275M	-372M
Change In Inventories	514M	-1.62B	-178M	-448M	-1.13B
Change In Accounts Payable	373M	476M	185M	224M	-
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	137M	71.35M	-74.09M	-615M	236M
Cash from Operations	2.1B	1.79B	993M	2.37B	2.3B
Capital Expenditure	-596M	-464M	-463M	-536M	-2.09B
Sale of Property, Plant, and Equipment	-	5.19M	340K	3.77M	8.54M
Cash Acquisitions	-	-	-	-266M	-
Investment in Marketable and Equity Securities, Total	-	-	-1.5M	-1.9B	-259M
Other Investing Activities, Total	967K	10.09M	47.6M	104M	931M
Cash from Investing	-595M	-449M	-417M	-2.59B	-1.41B
Short Term Debt Issued, Total	-	-	226M	52.96M	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	226M	52.96M	-
Short Term Debt Repaid, Total	-	-1.03M	-	-	-125M
Long-Term Debt Repaid, Total	-463M	-31.04M	-155M	-177M	-284M
Total Debt Repaid	-463M	-32.06M	-155M	-177M	-409M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-	-	-321M	-
Repurchase of Preferred Stock	-50M	-	-	-50M	-
Common Dividends Paid	-295M	-40.93M	-106M	-102M	-227M
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-295M	-40.93M	-106M	-102M	-227M
Other Financing Activities, Total	-92.95M	-79.86M	831M	2.58B	-51.72M
Cash from Financing	-901M	-153M	795M	1.98B	-687M
Foreign Exchange Rate Adjustments	-	-	-	20K	-
Net Change in Cash	603M	1.19B	1.37B	1.76B	208M
Supplemental Items
Cash Interest Paid	49.7M	34.68M	80.96M	91.28M	51.72M
Cash Income Tax Paid (Refund)	250M	485M	729M	630M	1.22B
Levered Free Cash Flow	1.35B	551M	-198M	661M	-510M
Unlevered Free Cash Flow	1.39B	575M	-162M	699M	-440M
Change In Net Working Capital	-698M	1.23B	1.48B	1.08B	1.5B
Net Debt Issued / Repaid	-463M	-32.06M	70.35M	-124M	-409M

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	12.5	18.37	9.33	9.39	9.86
Return on Total Capital	15.79	24.04	11.75	11.16	11.39
Return On Equity %	20.09	30.69	17.56	17.76	16.35
Return on Common Equity	20.49	31.33	17.89	18	16.47
Margin Analysis
Gross Profit Margin %	51.23	56.12	51.06	49.24	50.89
SG&A Margin	15.74	15.19	15.1	13.61	14.05
EBITDA Margin %	16.88	24.56	16.09	17.3	19.92
EBITA Margin %	15.24	23.15	14.6	16.1	18.2
EBIT Margin %	15	22.69	14.36	15.54	17.65
Income From Continuing Operations Margin %	10.65	17.28	12.53	14.33	14.46
Net Income Margin %	10.65	17.28	12.53	14.33	14.41
Net Avail. For Common Margin %	10.65	17.28	12.53	14.33	14.41
Normalized Net Income Margin	8.9	13.9	10.37	11.4	12.1
Levered Free Cash Flow Margin	11.91	3.99	-1.33	3.57	-2.34
Unlevered Free Cash Flow Margin	12.23	4.17	-1.09	3.78	-2.02
Asset Turnover
Asset Turnover	1.33	1.3	1.04	0.97	0.89
Fixed Assets Turnover